Skip to content

Pharmacokinetics study of food compounds.

Pharmacokinetics study of food compounds. - Pharmacokinetics study of food compounds.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061697
Enrollment
24
Registered
2026-05-26
Start date
2026-05-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Suntory Wellness Limited
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Healthy males who are 20 years of age or older at the time of obtaining consent and under 65 years of age at the end of the intake period (2) Individuals who fully understand the purpose and details of this study and provide written informed consent

Exclusion criteria

Exclusion criteria: (1)Individuals who are currently participating in another study as study subjects, who have participated in another study within 4 weeks after its completion. (2)Individuals who fall under any of the following categories: a) Individuals who have diseases of the heart, liver, or kidneys (including when such diseases are complications of other conditions) b) Individuals with a history of cardiovascular disease c) Individuals who have developed diabetes d) Individuals who have allergies to the test food (including load food or controlled diet, etc.) e) Individuals with a history of serious diseases such as cancer or tuberculosis. (3)Individuals who are receiving any kind of medical treatment at the time of obtaining consent. (4)Individuals with reduced renal function. (5)Individuals with a history of major gastrointestinal surgery, such as gastrectomy, gastrointestinal anastomosis, or intestinal resection. (6)Individuals who regularly consume Foods for Specified Health Uses (FOSHU), health food products, or other products that may affect the study results. (7)Individuals who the principal investigator determines to have difficulty swallowing capsules. (8)Individuals whose screening test results for syphilis, HBs antigen, HCV antibody, or HIV antigen/antibody are not negative. (9)Individuals who are judged by the principal investigator or sub-investigator to be unsuitable as study subjects

Design outcomes

Primary

MeasureTime frame
pharmacokinetic parameters

Countries

Japan

Contacts

Public ContactDAISUKE TAKEMOTO

Suntory Wellness Limited Institute for Science of Life

Daisuke_Takemoto@suntory.co.jp050-1804-0274

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026